Clinical features and treatment outcomes of Juvenile myoclonic epilepsy patients
Open Access
- 9 April 2019
- journal article
- research article
- Published by Wiley in Epilepsia Open
- Vol. 4 (2) , 302-308
Abstract
Objective: The aim of this study was to evaluate the clinical features and treatment outcomes of patients with juvenile myoclonic epilepsy (JME) in western China.Method: We continuously reviewed one hundred and five outpatients with JME who were diagnosed and treated at the Epilepsy Registration Center of West China Hospital between October 2012 and July 2014. Seizure control stratified into different seizure types and by antiepileptic drugs (AEDs) was prospectively evaluated every 3‐6 months.Results: Among 105 patients with JME, eighty‐five patients (81%) received monotherapy including valproate (VPA, 47%) and levetiracetam (LEV, 43%) treatment. The rates of seizure freedom 1, 3, and 5 years after the initiation of AED treatment were 64.8% (68/105), 29.5% (31/105), and 14.6% (12/82) in JME patients, respectively. Patients with myoclonic seizure (MS) and absence seizure (AS) were less frequently seizure‐free than those with MS and generalized tonic‐clonic seizure (GTCS) (P = 0.012). Patients on VPA monotherapy had better control of GTCS than patients on LEV monotherapy (P = 0.036). There is a trend of lower rates of seizure freedom in patients treated with LEV than in those treated with VPA after the first‐year treatment period.Significance: Our data suggest that in JME, seizure control is linked to seizure type, possibly allowing a more individualized approach when counseling JME patients.Keywords
This publication has 32 references indexed in Scilit:
- Juvenile myoclonic epilepsy 25 years after seizure onsetNeurology, 2009
- Myoclonic seizures subside in the fourth decade in juvenile myoclonic epilepsyNeurology, 2008
- Effects of levetiracetam on EEG abnormalities in juvenile myoclonic epilepsyEpilepsia, 2008
- Levetiracetam in juvenile myoclonic epilepsy: long‐term efficacy in newly diagnosed adolescentsDevelopmental Medicine & Child Neurology, 2007
- Placebo-controlled study of levetiracetam in idiopathic generalized epilepsyNeurology, 2007
- Levetiracetam: a long-term follow-up study of efficacy and safetyActa Neurologica Scandinavica, 2006
- Juvenile myoclonic epilepsy subsyndromes: family studies and long-term follow-upBrain, 2006
- Evolution of juvenile myoclonic epilepsy treated from the outset with sodium valproateSeizure: European Journal of Epilepsy, 2001
- Juvenile Myoclonic Epilepsy: A 5‐Year Prospective StudyEpilepsia, 1994
- Proposal for Classification of Epilepsies and Epileptic SyndromesEpilepsia, 1985